Imodium and Hepatitis c - a phase IV clinical study of FDA data

Summary:

Hepatitis c is reported as a side effect among people who take Imodium (loperamide hydrochloride), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Paracetamol, and have Primary pulmonary hypertension.

The phase IV clinical study analyzes which people have Hepatitis c when taking Imodium. It is created by eHealthMe based on reports of 44,210 people who have side effects when taking Imodium from the FDA, and is updated regularly.

What is Imodium?

Imodium has active ingredients of loperamide hydrochloride. It is often used in diarrhea. eHealthMe is studying from 45,092 Imodium users. Check the latest studies of Imodium.

What is Hepatitis c?

Hepatitis c is found to be associated with 788 drugs and 984 conditions by eHealthMe. Check the latest studies of Hepatitis c.

On Jul, 06, 2026

44,210 people reported to have side effects when taking Imodium.
Among them, 13 people (0.03%) have Hepatitis c.

Among these 13 people:

How long have people been on Imodium when they have Hepatitis c? *

What is the gender of people who have Hepatitis c when taking Imodium? *

female: 81.82 %
male: 18.18 %

What is the age of people who have Hepatitis c when taking Imodium? *

What are other drugs people take besides Imodium? *

What are other side effects people have besides Hepatitis c? *

Hepatocellular Injury (liver injury): 5 people, 38.46%
Hepatic Congestion (liver congestion): 2 people, 15.38%
Allergic Rhinitis: 2 people, 15.38%
Face Oedema (swelling of face): 2 people, 15.38%
Biliary Anastomosis Complication (complication of biliary-enteric anastomosis (bea) is a common surgical procedure): 2 people, 15.38%
Biliary Dilatation: 2 people, 15.38%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 2 people, 15.38%
Eye Swelling: 2 people, 15.38%
Pneumonia: 2 people, 15.38%
Hepatic Neoplasm Malignant (liver cancer): 2 people, 15.38%

What are the existing conditions these people have? *

Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 15.38%
Pain: 1 person, 7.69%
Immunodeficiency: 1 person, 7.69%
Headache (pain in head): 1 person, 7.69%
Fabry's Disease (build up of a particular type of fat, called globotriaosylceramide, in the body's cells): 1 person, 7.69%
Dementia (madness): 1 person, 7.69%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 1 person, 7.69%
Asthma: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Imodium and have Hepatitis c?

- Check whether Hepatitis c is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Imodium:

Imodium (45,092 reports)

Hepatitis c treatments and more:

Hepatitis c (131,813 reports)

Browse all side effects of Imodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatitis c:

Hepatitis c (788 drugs)

Browse all the conditions that are associated with Hepatitis c:

Hepatitis c (984 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on loperamide hydrochloride (the active ingredients of Imodium) and Imodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.